Reaching LDL-c targets in high-risk patients requires high-efficacy cholesterol-lowering drugs in more than 50% of cases. The results of the CHECK study

✍ Scribed by Andrea Poli; Manuela Casula; Elena Tragni; Ovidio Brignoli; Alessandro Filippi; Claudio Cricelli; Alberico L. Catapano

• Book ID: 119346924
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 100 KB
• Volume: 64
• Category: Article
• ISSN: 1043-6618
• DOI: 10.1016/j.phrs.2011.06.017